To assess whether loss of receptor expression was due to loss of heterozygosity (LOH), a common genomic mechanism of tumor suppressor inactivation in MSS colon cancers, we assayed for LOH at the ACVR2 and ACVR1 gene loci. The gene discussed is ACVR2A; the disease is malignant colon neoplasm.